Início › Câncer de Pulmão › Carolina do Norte

Ensaios clínicos de Câncer de Pulmão em Carolina do Norte

50 estudos para Câncer de Pulmão estão buscando participantes em locais em Carolina do Norte.

Cidades em Carolina do Norte

Texto oficial do estudo (Inglês)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Cone Health MedCenter Asheboro, Asheboro
Cone Health Cancer Center at Alamance Regional, Burlington
Wake Forest University at Clemmons, Clemmons
e mais 7

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04267848

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Duke University, Durham

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

Distance-Based Exercise to Preserve Function and Prevent Disability

Novant Health Cancer Institute - Kernersville, Kernersville
Novant Health Cancer Institute - Mount Airy, Mount Airy
Novant Health Forsyth Medical Center, Winston-Salem

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

AdventHealth Infusion Center Asheville, Asheville
Southeastern Medical Oncology Center-Clinton, Clinton
AdventHealth Infusion Center Haywood, Clyde
e mais 6

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Southeastern Medical Oncology Center-Clinton, Clinton
Southeastern Medical Oncology Center-Goldsboro, Goldsboro
Southeastern Medical Oncology Center-Jacksonville, Jacksonville

RecrutandoFase 3

Idades 70 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Novant Health Presbyterian Medical Center, Charlotte
Southeastern Medical Oncology Center-Clinton, Clinton
Southeastern Medical Oncology Center-Goldsboro, Goldsboro
e mais 7

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Duke Cancer Center Cary, Cary
Durham VA Medical Center, Durham
Duke University Medical Center, Durham
e mais 2

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06498635

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Carolinas Medical Center, Charlotte
Duke Cancer Center, Durham

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06765109

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

UNC Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT06881784

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site, Durham

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07127874

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]

GSK Investigational Site, Wilson

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07099898

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

FirstHealth Cancer Center, Pinehurst
FirstHealth Moore Regional Hospital, Pinehurst
Carolina Cancer Research Center, Wilson

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07222566

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Messino Cancer Centers Asheville, Asheville
Duke University Medical Center, Durham
FirstHealth Cancer Center, Pinehurst

RecrutandoFase 3

Idades de 18 a 100 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05920356

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Brody School of Medicine at East Carolina University, Greenville
ECU Health Medical Center, Greenville
Carolina Cancer Research Center, Wilson

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06758401

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Local Institution - 0514, Winston-Salem

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07063745

A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)

GSK Investigational Site, Wilson

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07602855

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Fletcher Hospital, Inc. dba AdventHealth Hendersonville, Hendersonville

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06712316

Study of Trilaciclib and Lurbinectidin

Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, Chapel Hill

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT05578326

Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07685938

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

Carolinas Medical Center/Levine Cancer Institute, Charlotte
Atrium Health Cabarrus/LCI-Concord, Concord
Wake Forest University Health Sciences, Winston-Salem

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT06287775

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Duke University School of Medicine, Durham

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT05786924

Effects of Infusion Timing on Treatment Response in Solid Tumors

University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07630168

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Firsthealth of The Carolinas, Pinehurst

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06793215

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

University of North Carolina Medical Center, Chapel Hill
Duke Cancer Institute, Durham

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06119581

The Vanguard Study: Testing a New Way to Screen for Cancer

UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Durham VA Medical Center, Durham

RecrutandoVoluntários saudáveis bem-vindos

Idades de 45 a 75 · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06995898

Health Education Approach to Lung Screening

University of North Carolina-Chapel Hill, Carrboro

RecrutandoVoluntários saudáveis bem-vindos

Idades de 50 a 80 · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT06070870

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Atrium Health Stanly/LCI-Albemarle, Albemarle
Duke Cancer Center Cary, Cary
UNC Lineberger Comprehensive Cancer Center, Chapel Hill
e mais 35

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05624996

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, Charlotte
Xencor Investigative Site, Durham

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT05433142

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

University of North Carolina at Chapel Hill, Chapel Hill
Duke University Medical Center, Durham

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 15 de jul. de 2026 · NCT05652686

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 14 de jul. de 2026 · NCT06896162

Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54

Levine Cancer Institute, Charlotte

RecrutandoVoluntários saudáveis bem-vindos

Idades de 40 a 54 · Todos os sexos · Atualizado em 13 de jul. de 2026 · NCT04577599

Integrated Cancer Repository for Cancer Research

Cape Fear Valley Health System, Fayetteville

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 19 a 110 · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT02012699

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

University of North Carolina, Chapel Hill

RecrutandoFase 2

Idades de 18 a 70 · Todos os sexos · Atualizado em 26 de jun. de 2026 · NCT04614103

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Research Site, Durham

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 10 de jun. de 2026 · NCT06835569

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Durham VA Medical Center, Durham

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 3 de jun. de 2026 · NCT05642572

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Duke Cancer Center, Durham
Carolina BioOncology Institute, Huntersville

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 3 de jun. de 2026 · NCT06040541

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

University of North Carolina at Chapel Hill, Chapel Hill

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 14 de mai. de 2026 · NCT06922591

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst

RecrutandoFase 2

18 Minutes · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Durham VA Medical Center, Durham
FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT06616584

Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

FirstHealth Cancer Center, Pinehurst

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 28 de abr. de 2026 · NCT05168566

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.